TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02390843 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT02429648 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT03067831 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04285723 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01859351 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01859351 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT01859351 — Predictive Biomarker (PRD): MAP2K2 mRNA
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study NCT02265952 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00809029 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00809029 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study NCT03466944 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03740880 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02345486 — Surrogate Endpoint (SUR): Serum sodium
Study NCT02345486 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01752920 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT00002967 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study NCT00002967 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03985137 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03385668 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT01100021 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02729129 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01252303 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01652833 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00058799 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT00058799 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04357847 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT04357847 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT04357847 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00392873 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01682915 — Predictive Biomarker (PRD): SLC6A3 mRNA
Genes: SLC6A3; DAT1
Study NCT01682915 — Predictive Biomarker (PRD): DRD1 mRNA
Genes: DRD1
Study NCT01682915 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study NCT01682915 — Predictive Biomarker (PRD): DRD4 mRNA
Genes: DRD4
Study NCT01682915 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DRD5 mRNA
Genes: DRD5; DRD1B; DRD1L2
Study NCT01682915 — Predictive Biomarker (PRD): DBH mRNA
Genes: DBH
Study NCT01682915 — Predictive Biomarker (PRD): ADRA2A mRNA
Genes: ADRA2A; ADRA2R; ADRAR
Study NCT01682915 — Predictive Biomarker (PRD): ADRA2C mRNA
Genes: ADRA2C; ADRA2L2; ADRA2RL2
Study NCT01682915 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT03009695 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT00503971 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00503971 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00860106 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01914718 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT04396912 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03035461 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03035461 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02756000 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT01504113 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01504113 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT03275701 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04033523 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04033523 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT04033523 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01009281 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT01360450 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03714841 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00876798 — Surrogate Endpoint (SUR): Serum sodium
Study NCT05895851 — Predictive Biomarker (PRD): MST1R mRNA
Genes: MST1R; PTK8; RON
Study NCT02739412 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04121910 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01738035 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01738035 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03191175 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT01305369 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study NCT02058381 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02058381 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01370954 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00190086 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT03924531 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01511393 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT03610412 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT03610412 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03647787 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04079673 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05890391 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02907619 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01401959 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01401959 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01791556 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02312427 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02312427 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT02249507 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01255384 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT03510247 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01677390 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT00812695 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02414139 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02414139 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02414139 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02414139 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03277833 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01974180 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02879500 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00142363 — Predictive Biomarker (PRD): SCN1A mRNA
Genes: SCN1A; NAC1; SCN1
Study NCT00142363 — Predictive Biomarker (PRD): SCN1B mRNA
Genes: SCN1B
Study NCT00142363 — Predictive Biomarker (PRD): GABRG2 mRNA
Genes: GABRG2
Study NCT00520052 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02305420 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02741115 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT00001282 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00361725 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT02874768 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01422733 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT01958112 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00235859 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01533155 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT06516601 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03052933 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01943461 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02433158 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03608423 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03548571 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT01096667 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00059995 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT04932070 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04932070 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03231982 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02263365 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT02435628 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02435628 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT03455049 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03455049 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04151342 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04151342 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04151342 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04151342 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02750215 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00025805 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01478750 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00072189 — Predictive Biomarker (PRD): UCN mRNA
Genes: UCN
Study NCT04272957 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04272957 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT02415166 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00023192 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01240265 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03233269 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04254042 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02007837 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02592187 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03729362 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT03830138 — Predictive Biomarker (PRD): OLR1 mRNA
Genes: OLR1; CLEC8A; LOX1
Study NCT03830138 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03762538 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study NCT04526587 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04927650 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03518840 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study NCT01207544 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study NCT03911310 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04901338 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01611454 — Predictive Biomarker (PRD): DNA repair endonuclease XPF
Genes: ERCC4; ERCC11; XPF
Study NCT01461057 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02102490 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02102490 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03721679 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00284141 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03894592 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05003830 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02875951 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02875951 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02573038 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02573038 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02480010 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02357277 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00003995 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00306332 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00306332 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00265941 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00265941 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03963544 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT03963544 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT03425656 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03425656 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03425656 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02446639 — Predictive Biomarker (PRD): TNNT1 mRNA
Genes: TNNT1; TNT
Study NCT05737329 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT05737329 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04211805 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04211805 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04581187 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00337636 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study NCT00036777 — Predictive Biomarker (PRD): UCN mRNA
Genes: UCN
Study NCT02437643 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00419159 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00419159 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00419159 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT00553501 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05041764 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03745430 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02771587 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT01245361 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00003184 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT01082757 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03695328 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03695328 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02839382 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04375098 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01041677 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03573102 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03573102 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01677455 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04695587 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02099968 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00955383 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00715715 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00240474 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04265534 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT04265534 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT04265534 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03865719 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00307879 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04300543 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-150
Genes: MIR150
Study NCT04300543 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study NCT01856283 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00756925 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT01631019 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01055496 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT00146107 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04637828 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01048099 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02449564 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04509089 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05387330 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study NCT01923168 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01923168 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01923168 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01923168 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01466595 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04661020 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00630032 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00201201 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01410383 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03534297 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00858819 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01429038 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04133324 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01815021 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00106028 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00542451 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04094194 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01172886 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02441803 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study NCT01729247 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03858439 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT00626483 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02889276 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03450850 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT02988804 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01690962 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT01094899 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02862210 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04431869 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01501344 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study NCT00871858 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03096028 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03096028 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03096028 — Safety Biomarker (SAF): BDNF
Study NCT03560869 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04407507 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02046928 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT00884143 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00015639 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Platelet glycoprotein 4
Genes: CD36; GP3B; GP4
Study NCT00015639 — Predictive Biomarker (PRD): HRG mRNA
Genes: HRG
Study NCT03220230 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03220230 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT02645318 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02756455 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT02756455 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02756455 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00791700 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01874418 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02039440 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00098631 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00098631 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02885168 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5